Low-resolution electromagnetic tomography and treatment response in obsessive-compulsive disorder.

We investigated whether findings from pretreatment low-resolution electromagnetic tomography (LORETA) predicted response to drug treatment in patients with obsessive-compulsive disorder (OCD). The 3D intra-cerebral distribution of neuronal electrical activity from the scalp-recorded potential distribution of 17 drug-free patients with OCD was assessed with LORETA. They were treated with antidepressants in the maximum tolerated doses for at least 12 wk. Individuals were considered to be treatment responders if they displayed a reduction of at least 35% on the initial YBOCS scores and had a final CGI score of 1 or 2. The SPM-99 t test for independent samples was employed to compare, voxel-by-voxel, the brain electrical activities of responders (n = 10) and non-responders (n = 7). Responders exhibited significantly lower activities in beta band in the rostral anterior cingulate [Brodmann's area (BA) 24 and 32] (p = 0.002) and the medial frontal gyrus (BA 10) (p = 0.002), suggesting that a distinctive pattern of activity within the medial surface of the frontal lobe predicts therapeutic response in OCD.

[1]  H. Leonard,et al.  Obsessive-compulsive disorder. , 2003, Child and adolescent psychiatric clinics of North America.

[2]  F. Vollenweider,et al.  Comparison of simultaneously recorded [H215O]‐PET and LORETA during cognitive and pharmacological activation , 2004, Human brain mapping.

[3]  Pedro Ribeiro,et al.  Neurocortical electrical activity tomography in chronic schizophrenics. , 2003, Arquivos de neuro-psiquiatria.

[4]  Dennis Velakoulis,et al.  Anterior cingulate dysfunction: implications for psychiatric disorders? , 2003, Journal of psychiatry & neuroscience : JPN.

[5]  Cameron S. Carter,et al.  Overactive Action Monitoring in Obsessive-Compulsive Disorder , 2003, Psychological science.

[6]  Matthew L. Ho,et al.  Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. , 2003, The American journal of psychiatry.

[7]  F. Karadağ,et al.  QUANTITATIVE EEG ANALYSIS IN OBSESSIVE COMPULSIVE DISORDER , 2003, The International journal of neuroscience.

[8]  N. Alpert,et al.  Predictors of Fluvoxamine Response in Contamination-related Obsessive Compulsive Disorder: A PET Symptom Provocation Study , 2002, Neuropsychopharmacology.

[9]  A. Özge,et al.  Association of QEEG Findings with Clinical Characteristics of OCD: Evidence of Left Frontotemporal Dysfunction , 2002, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[10]  Leonardo Franklin Fontenelle,et al.  The effect of gender on the clinical features and therapeutic response in obsessive-compulsive disorder , 2002 .

[11]  D. Lehmann,et al.  Functional imaging with low-resolution brain electromagnetic tomography (LORETA): a review. , 2002, Methods and findings in experimental and clinical pharmacology.

[12]  R. Davidson,et al.  Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. , 2001, The American journal of psychiatry.

[13]  S. Alborzian,et al.  Localized Orbitofrontal and Subcortical Metabolic Changes and Predictors of Response to Paroxetine Treatment in Obsessive-Compulsive Disorder , 1999, Neuropsychopharmacology.

[14]  J. Lorberbaum,et al.  Mirtazapine treatment of obsessive-compulsive disorder , 1999, European Neuropsychopharmacology.

[15]  P. Fox,et al.  Cingulate function in depression: a potential predictor of treatment response , 1997, Neuroreport.

[16]  M. First,et al.  Structured clinical interview for DSM-IV axis I disorders : SCID-I : clinical version : scoresheet , 1997 .

[17]  Karl J. Friston,et al.  Detecting Activations in PET and fMRI: Levels of Inference and Power , 1996, NeuroImage.

[18]  J. R. Baker,et al.  Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. , 1996, Archives of general psychiatry.

[19]  D. Zabel,et al.  Diagnostic and Statistical Manual of Mental Disorders, 4th ed , 1995 .

[20]  Suck-Won Kim,et al.  The Yale-Brown Obsessive-Compulsive Scale: Measures of internal consistency , 1994, Psychiatry Research.

[21]  P Pietrini,et al.  Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. , 1992, Archives of general psychiatry.

[22]  W. Goodman,et al.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. , 1989, Archives of general psychiatry.

[23]  J. Rapoport,et al.  Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. , 1989, Archives of general psychiatry.

[24]  M. Hamilton,et al.  Development of a rating scale for primary depressive illness. , 1967, The British journal of social and clinical psychology.